Long-Term Follow-up Study (LTFS): An Observational Long-term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy

Caribou's CAR-T cell product is a genetically modified cell therapy, meaning it is designed to change the expression of a gene or alter natural properties of living cells. Healthy donor T cells have been altered. The US Food and Drug Administration (FDA) requires long-term observation for 15 years after infusion of genetically modified cell therapy products. The purpose of this research study is to collect long-term observational data to identify and understand any potential late side effects in participants who have received Caribou’s cell products.